Impaired consciousness has long been considered the hallmark of epileptic seizures. Both generalized seizures and complex partial seizures are characterized by a multifaceted spectrum of altered ...
Background A 20-year-old woman presented to a specialist epilepsy center with a 3-year history of drug-resistant epileptic seizures, progressive myoclonus, ataxia, and cognitive decline.
LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
Two NDA submissions expected by mid-February 2026 for ulixacaltamide in essential tremor and relutrigine in SCN2A/8A-DEEs, both with Breakthrough ...
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...
Neurofeedback treatments are aimed at assisting those struggling with ADHD, generalized anxiety, depression, post-traumatic stress disorder and other neurological-based disorders.
Xenon Pharmaceuticals Inc. Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026. Five additional Phase 3 azetu ...
Techno-Science.net on MSN
⚕️ Medical cannabis: Between myths and scientific realities
While medical cannabis is gaining popularity for its supposed benefits, a large-scale synthesis led by experts from UCLA ...
Epilepsy is one of the most common neurological disorders in the world. According to the World Health Organization, around 50 ...
An internationally validated, imaging-based score helps clinicians better identify patients with stroke at highest risk for ...
Epilepsy organizations unite to express concerns about leadership change at the National Institute of Neurological Disorders and Stroke.
NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, what you need to know about epilepsy — including how to recognize a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results